Naamit K Gerber (Naamit Gerber)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Breast cancer research and treatment

The breast journal

This page only lists publications with an associated author ORCID identifier.

Publications

Camille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, David Barbee, Bhartesh Shah, Olivier Maisonet, Carmen Perez, Sylvia Adams, Freya Schnabel, Deborah Axelrod, Amber Guth, Nolan Karp, Oren Cahlon, Naamit K Gerber
Effectiveness and toxicity of five-fraction prone accelerated partial breast irradiation. Breast cancer research and treatment 204 (3) (2024)
Camille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, David Barbee, Bhartesh Shah, Olivier Maisonet, Carmen Perez, Sylvia Adams, Freya Schnabel, Deborah Axelrod, Amber Guth, Nolan Karp, Oren Cahlon, Naamit K Gerber
Effectiveness and toxicity of five-fraction prone accelerated partial breast irradiation. Breast cancer research and treatment 204 (3) (2024)
Camille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, David Barbee, Bhartesh Shah, Olivier Maisonet, Carmen Perez, Sylvia Adams, Freya Schnabel, Deborah Axelrod, Amber Guth, Nolan Karp, Oren Cahlon, Naamit K Gerber
Effectiveness and toxicity of five-fraction prone accelerated partial breast irradiation. Breast cancer research and treatment (2024)
Camille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, David Barbee, Carmen A Perez, Ruth Oratz, Freya Schnabel, Deborah Axelrod, Amber Guth, Lior Z Braunstein, Atif Khan, J Isabelle Choi, Naamit K Gerber
Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer. Breast cancer research and treatment 198 (1) (2023)
Camille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, David Barbee, Carmen A Perez, Ruth Oratz, Freya Schnabel, Deborah Axelrod, Amber Guth, Lior Z Braunstein, Atif Khan, J Isabelle Choi, Naamit K Gerber
Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer. Breast cancer research and treatment 198 (1) (2023)
Camille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, David Barbee, Carmen A Perez, Ruth Oratz, Freya Schnabel, Deborah Axelrod, Amber Guth, Lior Z Braunstein, Atif Khan, J Isabelle Choi, Naamit K Gerber
Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer. Breast cancer research and treatment 198 (1) (2023)
Camille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, David Barbee, Carmen A Perez, Ruth Oratz, Freya Schnabel, Deborah Axelrod, Amber Guth, Lior Z Braunstein, Atif Khan, J Isabelle Choi, Naamit K Gerber
Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer. Breast cancer research and treatment (2023)
Susanna Nguy, S Peter Wu, Cheongeun Oh, Naamit K Gerber
Outcomes of HER2-positive non-metastatic breast cancer patients treated with anti-HER2 therapy without chemotherapy. Breast cancer research and treatment 187 (3) (2021)
Sherry X Yan, Olivier G Maisonet, Carmen A Perez, Nelly Huppert, Christine J Hitchen, Indra J Das, Naamit K Gerber
Radiation effect on late cardiopulmonary toxicity: An analysis comparing supine DIBH versus prone techniques for breast treatment. The breast journal 26 (5) (2020)

Naamit K Gerber.css-eqlu8i{font-size:small;padding-left:4px;} (Naamit Gerber)

Publication Activity (10 Years)

Top Topics

Top Venues

Naamit K Gerber (Naamit Gerber)